Open access
Open access
Powered by Google Translator Translator

All Posts

2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

2 Aug, 2023 | 14:02h | UTC

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease – Arthritis & Rheumatology

Commentary: 2023 ACR/EULAR Criteria for Calcium Pyrophosphate Deposition Disease – RheumNow

 

BSH guideline for anticoagulant management of pregnant individuals with mechanical heart valves

2 Aug, 2023 | 14:01h | UTC

British Society for Haematology guideline for anticoagulant management of pregnant individuals with mechanical heart valves – British Journal of Haematology

 

RCT | Multiple sclerosis disease-modifying therapy continuation versus discontinuation in older individuals

2 Aug, 2023 | 14:00h | UTC

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial – The Lancet Neurology (link to abstract – $ for full-text)

Commentaries:

Study investigates risk when discontinuing therapy for MS patients over 55 – CU Anschutz Medical Campus

Discontinuing Multiple Sclerosis Therapies at Age 55 or Older – NEJM Journal Watch

 

Debate | Do all patients with asymptomatic severe aortic stenosis need valve replacement?

2 Aug, 2023 | 13:58h | UTC

Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement – European Heart Journal

 

Commentary on Twitter

 

RCT | Atogepant outperforms placebo in reducing migraines over 12 weeks

2 Aug, 2023 | 13:56h | UTC

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)

 

RCT | Lazertinib offers 20.6-month of median PFS in EGFR-mutated NSCLC vs 9.7 months with gefitinib

2 Aug, 2023 | 13:55h | UTC

Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301 – Journal of Clinical Medicine

 

RCT | Camrelizumab-rivoceranib outperforms sorafenib as first-line therapy for unresectable HCC

2 Aug, 2023 | 13:53h | UTC

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study – The Lancet (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Case Report | Post-myocardial infarction free-wall rupture: rapid diagnosis and management

2 Aug, 2023 | 13:52h | UTC

Post-Myocardial Infarction Free-Wall Rupture: Rapid Diagnosis and Management – JACC: Case Reports

 

Commentary on Twitter

 

M-A | High-volume disease, T stage 4 show largest docetaxel benefit in prostate cancer

2 Aug, 2023 | 13:51h | UTC

Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials – The Lancet Oncology

Commentaries:

Meta-analysis of the Addition of Docetaxel to ADT in Metastatic Hormone-Sensitive Prostate Cancer – The ASCO Post

Disease Volume and T Stage Affect Docetaxel/ADT Efficacy in Prostate Cancer – Cancer Network

 

Commentary on Twitter

 

Cohort Study | Depression at any life stage linked to increased dementia incidence

2 Aug, 2023 | 13:49h | UTC

Association of Early-, Middle-, and Late-Life Depression With Incident Dementia in a Danish Cohort – JAMA Neurology (link to abstract – $ for full-text)

Commentary: Depression Over Adulthood May Increase Risk of Dementia – Psychiatric News Alert

 

RCT | Maternal egg intake in early neonatal period does not impact infant egg allergy risk

2 Aug, 2023 | 13:47h | UTC

Effect of Maternal Egg Intake During the Early Neonatal Period and Risk of Infant Egg Allergy at 12 Months Among Breastfeeding Mothers: A Randomized Clinical Trial – JAMA Network Open

See also: Visual Abstract

 

RCT | Baricitinib demonstrates efficacy in treatment-resistant juvenile idiopathic arthritis

2 Aug, 2023 | 13:45h | UTC

Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial – The Lancet (link to abstract – $ for full-text)

 

Commentary on Twitter

 

RCT | Platelet-rich plasma injections lack efficacy in 52-week ankle osteoarthritis study

2 Aug, 2023 | 13:43h | UTC

Platelet-Rich Plasma Injections for the Treatment of Ankle Osteoarthritis – The American Journal of Sports Medicine

 

RCT | Early vs. delayed intrauterine balloon tamponade: no difference in severe postpartum hemorrhage

2 Aug, 2023 | 13:42h | UTC

Efficacy of early intrauterine balloon tamponade for immediate postpartum hemorrhage after vaginal delivery: a randomized clinical trial – The American Journal of Obstetrics and Gynecology (link to abstract  – $ for full-text)

 

Consensus Paper | Diagnosis and management of infective endocarditis in adults

1 Aug, 2023 | 14:34h | UTC

Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement – JAMA Network Open

 

Review | Futility in clinical trials

1 Aug, 2023 | 14:32h | UTC

Futility in Clinical Trials – JAMA (free for a limited period)

 

Study | AI use in lung cancer screening enhances prediction of lung cancer death, CVD death, and all-cause death

1 Aug, 2023 | 14:31h | UTC

AI Body Composition in Lung Cancer Screening: Added Value Beyond Lung Cancer Detection – Radiology (free for a limited period)

Commentary: Study: AI Assessment of Chest CT May Predict Multiple Mortality Risks – Diagnostic Imaging

 

Opinion | Bad science needs to be called out: the medical profession loses trust when bad studies are used to promote policy

1 Aug, 2023 | 14:29h | UTC

Bad Science Needs to Be Called Out – Sensible Medicine

Related: Did Republicans die more during the pandemic bc they didn’t get the vax? – By Dr. Vinay Prassad

Original Study: Excess Death Rates for Republican and Democratic Registered Voters in Florida and Ohio During the COVID-19 Pandemic – JAMA Internal Medicine

 

Critical Appraisal | Did Republicans die more during the pandemic bc they didn’t get the vax?

1 Aug, 2023 | 14:28h | UTC

Did Republicans die more during the pandemic bc they didn’t get the vax? – By Dr. Vinay Prassad

Related: Bad Science Needs to Be Called Out – Sensible Medicine

Original Study: Excess Death Rates for Republican and Democratic Registered Voters in Florida and Ohio During the COVID-19 Pandemic – JAMA Internal Medicine

 

ESPEN Updated Guideline | Clinical nutrition in the intensive care unit

1 Aug, 2023 | 14:27h | UTC

ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit – Clinical Nutrition

 

AAP Policy Statement | Pediatric organ donation and transplantation: across the care continuum

1 Aug, 2023 | 14:26h | UTC

Pediatric Organ Donation and Transplantation: Across the Care Continuum – Pediatrics

News Release: Policy underscores role of medical home in pediatric organ donation, transplantation – AAP News

Commentary: Pediatric Organ Donation and Transplantation: What Primary Care Providers and Families Should Know – AAP Journal Blog

 

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma

1 Aug, 2023 | 14:24h | UTC

Part 1: Diagnostics and prevention – European Journal of Cancer

Part 2: Treatment – European Journal of Cancer

 

International Study | Postoperative acute kidney injury affects one in five patients after major surgery

1 Aug, 2023 | 14:23h | UTC

Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study – Intensive Care Medicine

 

Commentary on Twitter

 

Novel therapeutics for management of lupus nephritis: what is next?

1 Aug, 2023 | 14:22h | UTC

Novel Therapeutics for Management of Lupus Nephritis: What Is Next? – Kidney Medicine

Related: Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis – Nefrología

 

Nonrandomized Controlled Trial | Long-term survival of 80% in selected colorectal cancer patients post liver transplant

1 Aug, 2023 | 14:20h | UTC

Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial – JAMA Surgery (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.